Crossref indexed
Hematological Oncology
Published by Wiley (John Wiley & Sons).
ISSN 0278-0232 / 1099-1069
Submit to this journal
01
Aims & scope
Hematological Oncology publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.
02
Recently published
Untitled
DOI 10.1002/hon.v44.6 Authors not listed ¡ 2026
Navigating Measurable Residual Disease as a Surrogate Endpoint in Chronic Lymphocytic Leukemia
DOI 10.1002/hon.70287 Stefano Molica ¡ 2026
Baseline Monoclonal Protein Identifies Plasmacytic Differentiation and Shorter ProgressionâFree Survival in Marginal Zone Lymphoma
DOI 10.1002/hon.70286 Wei Wang, Danqing Zhao, Chen Yang, Lu Zhang, Wei Zhang, Daobin Zhou, Yan Zhang, Jian Li ¡ 2026
Adjusted Indirect Comparison Between EpcoritamabâR
<sup>2</sup>
and TafasitamabâR
<sup>2</sup>
in Relapse/Refractory Follicular Lymphoma
DOI 10.1002/hon.70282 Leonidas Benetatos, Elisavet Apostolidou, Vasileios Georgoulis, Georgios S. Markopoulos, Savvas Dimitriadis, Eleftheria Hatzimichael, Eleni Kapsali ¡ 2026
APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma
DOI 10.1002/hon.70269 Dimitris Vraxnos, Paris Vogazianos, Cameron Brown, Marta Lionetti, Juan Carlos Entizne, Emily Charalambous, Athos Antoniades, Niccolo Bolli ¡ 2026
Characterization of Adverse Cutaneous Effects in the Setting of Ponatinib, Bosutinib, and Asciminib for Chronic Myeloid Leukemia Patients
DOI 10.1002/hon.70280 Ruhi Kanwar, Juna Khang, Goranit Sakunchotpanit, Ruhi Nayak, Nicole R. LeBoeuf, Vinod E. Nambudiri ¡ 2026
Teclistamab Induced a Profound Hematologic Response in Light Chain Deposition Disease With Probable Cardiac Involvement
DOI 10.1002/hon.70278 Xinyi Xiong, Danqing Zhao, Jian Li, Kaini Shen ¡ 2026
NonâRelapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis
DOI 10.1002/hon.70268 Sohaib Irfan, Harshit Khosla, Saad Nasir, Manmeet Kaur, Tyler J. Varisco, Onyebuchi Ononogbu, Sharda Singh, Muhammad Bilal Abid ¡ 2026
NFS1 as a Metabolic Vulnerability in Acute Myeloid Leukemia Through Iron Dysregulation and STAT1/IFIT2âAssociated Signaling
DOI 10.1002/hon.70277 Ying Liu, Ziyi Wei, Bingxin Qian, Xiaoya Cai, Guiqin Huang, Lulu Zhang, Dengju Li ¡ 2026
Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and
<i>BCR::ABL1</i>
Negative Myeloproliferative Neoplasms: A Retrospective Study
DOI 10.1002/hon.70273 Yanan Cai, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Qingyan Gao, Meng Jiao, Songyang Zhao, Fuhui Li, Ningning Liu, Zunmin Zhu, Bing Li, Zhijian Xiao, Tiejun Qin ¡ 2026
RealâWorld Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis
DOI 10.1002/hon.70253 Mariarita Sciumè, Alessandro Bosi, Alfredo Marchetti, Fabio Serpenti, Pasquale De Roberto, Sonia Fabris, Francesco Versino, Elena Tagliaferri, Francesco Passamonti, Nicola Stefano Fracchiolla ¡ 2026
The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL
DOI 10.1002/hon.70275 Michal Masar, Joseph P. Novak, Janek S. Walker, Prokop Vodicka, Abigail R. Dropik, Zilin Xianyu, Matthew J. Maurer, Thomas M. Habermann, Eric Mou, Rebecca L. King, Kerstin Wenzl, Thomas E. Witzig, Stephen M. Ansell, Pavel Klener, James R. Cerhan, Marek Trneny, Yucai Wang, Magdalena Klanova, Anne J. Novak ¡ 2026
Journal metrics
Total DOIs6,048
Current DOIs1,292
Backfile DOIs4,756
Published here0
Publish with us
Five steps, about 15 minutes. You can save and come back at any point.
Submit manuscript